These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Biological markers for diagnosis of Alzheimer's disease]. Takeda M; Tanaka T; Kudo T; Okochi M; Kamino A; Tagami S Seishin Shinkeigaku Zasshi; 2004; 106(12):1610-4. PubMed ID: 15770965 [No Abstract] [Full Text] [Related]
4. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease. Montalto MC; Farrar G; Hehir CT Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026 [TBL] [Abstract][Full Text] [Related]
5. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Blennow K Expert Rev Mol Diagn; 2005 Sep; 5(5):661-72. PubMed ID: 16149870 [TBL] [Abstract][Full Text] [Related]
6. Relationship of amyloid to Alzheimer's disease. Vinters HV West J Med; 1991 Jan; 154(1):94-5. PubMed ID: 2024520 [No Abstract] [Full Text] [Related]
7. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy. Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362 [TBL] [Abstract][Full Text] [Related]
8. [Proteins, genes and early diagnosis of Alzheimer's disease]. Laplanche JL; Chatelain J; Launay JM; Dreux C Ann Biol Clin (Paris); 1990; 48(5):281-5. PubMed ID: 2195924 [TBL] [Abstract][Full Text] [Related]
9. A turn of the sulfatide in Alzheimer's disease. Irizarry MC Ann Neurol; 2003 Jul; 54(1):7-8. PubMed ID: 12838515 [No Abstract] [Full Text] [Related]
10. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease. Zetterberg H Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126 [TBL] [Abstract][Full Text] [Related]
11. New tests for Alzheimer's disease. Health News; 2006 Jun; 12(6):2. PubMed ID: 16826618 [No Abstract] [Full Text] [Related]
12. [Use of CSF biomarkers in the diagnostics of memory diseases]. Remes A; Leikola M; Majamaa K; Nikkanen M; Ruokonen LI; Rusanen M; Tapiola T; Ylikotila P; Vallittu AM; Pirttilä T Duodecim; 2009; 125(20):2215-22. PubMed ID: 19998760 [TBL] [Abstract][Full Text] [Related]
13. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease? Nichols L; Pike VW; Cai L; Innis RB Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944 [TBL] [Abstract][Full Text] [Related]
14. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Swerdlow RH Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of Alzheimer's disease]. Delacourte A Ann Biol Clin (Paris); 1998; 56(2):133-42. PubMed ID: 9754238 [TBL] [Abstract][Full Text] [Related]
17. [The progress of Alzheimer's disease research biomarkers--sensitivity and specificity]. Shoji M Rinsho Shinkeigaku; 2000 Dec; 40(12):1234-6. PubMed ID: 11464465 [TBL] [Abstract][Full Text] [Related]
18. [The neurobiology and molecular genetics of Alzheimer's disease: the diagnostic markers and therapy]. Cacabelos R Med Clin (Barc); 1990 Oct; 95(13):502-16. PubMed ID: 2150683 [No Abstract] [Full Text] [Related]
19. The immune system, amyloid-beta peptide, and Alzheimer's disease. Weksler ME; Gouras G; Relkin NR; Szabo P Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358 [TBL] [Abstract][Full Text] [Related]